Protak Scientific invest in new premises

Published: 23-May-2018
Estates & Facilities Pharmaceutical

Protak Scientific will shortly be moving to brand new offices in Merstham, Surrey


Protak Scientific announced that it will be shortly moving to brand new offices in Merstham, Surrey.

Investing more than a million pounds is never an easy decision, said the company. However, it is the natural progression to support its growing multinational pharmaceutical customer base.

Phillip Godden, CEO of Protak Scientific said: “To support our worldwide growth we have obtained new offices in Merstham Surrey, the offices are currently undergoing a refurbishment programme, which will see the installation of a graded and qualified GMP facility for long-term production."

“We are investing in our success so far with a facility that will support our long-term growth and that of our distributors worldwide."

  • Companies:
  • Protak Scientific
See more

You may also like

Analysis

Phillip Godden speaks up about Enzyme Indicator technology

Read more
What is the market penetration of the EI technology and why should companies consider the new method for bio-decontamination validation? Phillip Godden, Protak Scientific CEO, answers these questions and comments on the support received by the MHRA

Trending Articles

  1. Merit and Getinge to start work as NHS Medicines Manufacturing Centre gets the green light Construction expert Merit has been appointed for the design and fit-out of the sterile medicine facility, while Getinge has been chosen to provide the necessary high-tech isolator equipment
  2. Contractors Sisk set to finish ISG’s £200m Teesside vaccine plant Sisk is in talks to finish the £200m vaccine manufacturing factory contract in Teesside following the collapse of ISG, the former contractor on the project
  3. EXCLUSIVE: Mona Åkerholm from Elomatic gives update on Biovian facility build Mona Åkerholm, Senior VP of Pharma Services at Elomatic, in conversation with the Editor of Cleanroom Technology, Sophie Bullimore, shared an exclusive update on the build of Biovian's new biopharmaceutical facility
  4. The importance of growth promotion testing Given the critical nature of microbiological quality tests which are employed to ensure that pharmaceutical products are safe for human use, it is in turn essential to undertake quality control (QC) tests to ensure that the culture media being used for these is fit for purpose and performs properly. Cherwell Laboratories' Steven Brimble explains
  5. Cherwell highlighting microbiology EM products at Pharmaceutical Microbiology Conference Cleanroom microbiology specialists supported by AnalytiChem Group team members at Pharmig’s 32nd Annual Conference

Upcoming event

Pharmig Annual Pharmaceutical Microbiology Conference

20–21 November 2024 | Conference | Nottingham, UK See all

You may also like

Analysis

Phillip Godden speaks up about Enzyme Indicator technology

What is the market penetration of the EI technology and why should companies consider the new method for bio-decontamination validation? Phillip Godden, Protak Scientific CEO, answers these questions and comments on the support received by the MHRA
Design & Build

WuXi XDC chooses Pharmadule for modular ADC facility build

Modular pharmaceutical build expert Phamadule has shipped nearly 100 ADC production modules to WuXi XDC's Singapore manufacturing site
Finance

Azbil completes transfer of aseptic process solutions to expert Telstar to Syntegon

Japan-based Azbil Corporation has officially transferred all of the equity interests in its European subsidiary Azbil Telstar to a wholly owned subsidiary of Syntegon Technology
Containment

Pharmaceutical containment firm Dec Group opens subsidiary in Japan

Dec (Dietrich Engineering Consultants) Group is a global provider of contained powder handling systems that is looking to boost brand identity in Japan
Pharmaceutical

Cherwell highlighting microbiology EM products at Pharmaceutical Microbiology Conference

Cleanroom microbiology specialists supported by AnalytiChem Group team members at Pharmig’s 32nd Annual Conference
Design & Build

EXCLUSIVE: Mona Åkerholm from Elomatic gives update on Biovian facility build

Mona Åkerholm, Senior VP of Pharma Services at Elomatic, in conversation with the Editor of Cleanroom Technology, Sophie Bullimore, shared an exclusive update on the build of Biovian's new biopharmaceutical facility
Design & Build

Merit and Getinge to start work as NHS Medicines Manufacturing Centre gets the green light

Construction expert Merit has been appointed for the design and fit-out of the sterile medicine facility, while Getinge has been chosen to provide the necessary high-tech isolator equipment
Subscribe now